Iovance Biotherapeutics Inc (IOVA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

999 SKYWAY ROAD SAN CARLOS, CA 94070

Iovance Biotherapeutics, Inc. operates as a biotechnology company. The Company focuses on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes for treatment of patients with cancer. Iovance Biotherapeutics serves customers in the United States.

Data based on most recent fiscal year report
Market Cap2.987 Billion Shares Outstanding126.2 Million Avg Volume1.844 Million
1-Yr BETA vs S&P TR1.585 Current Ratio33.01 Quick Ratio33.01
View SEC Filings from IOVA instead.

View recent insider trading info

Funds Holding IOVA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IOVA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COUNTOURIOTIS ATHENA PRESIDENT & CEO

  • Officer
  • Director
22,706 2020-01-06 2

FARDIS MARIA PRESIDENT AND CEO

  • Officer
  • Director
0 2020-01-03 4

VOGT FREDERICK G GENERAL COUNSEL

  • Officer
0 2020-01-03 2

GRAF FINCKENSTEIN FRIEDRICH CHIEF MEDICAL OFFICER

  • Officer
0 2020-01-03 3

VENKATESAN JAY

  • Director
  • 10% Owner
0 2020-01-02 0

VALLE FRANCO SENIOR VICE PRESIDENT, FINANCE

  • Officer
0 2020-01-01 0

KESSLER PAUL L. EXECUTIVE CHAIRMAN

  • Officer
  • 10% Owner
0 2019-12-31 0

SCHIFFMAN GREGORY T

19,169 2019-12-31 0

MCPEAK MERRILL A

  • Director
0 2019-11-12 1

HENDERSON MOLLY EXECUTIVE VICE PRESIDENT & CFO

  • Officer
0 2019-10-24 0

CATALDO TONY CEO

  • Officer
  • Director
  • 10% Owner
10,734,320 2019-08-14 0

MCKILLIGAN RICHARD CHIEF FINANCIAL OFFICER

  • Officer
0 2019-06-27 0

MAYNARD RYAN D

  • Director
0 2019-06-10 1

DUKES IAIN D.

  • Director
0 2019-06-10 1

WEISER MICHAEL

  • Director
0 2019-06-10 1

MORRIS TIMOTHY E CHIEF FINANCIAL OFFICER

  • Officer
0 2019-03-04 1

ROTHBAUM WAYNE P.

  • Director
7,067,333 2018-12-04 0

HILLSBERG SANFORD

  • Director
56,950 2017-10-10 0

AHN MARK J

  • Director
0 2016-12-13 0

BROOKE ROBERT T. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2016-07-15 0

BRISTOL INVESTMENT FUND LTD

  • 10% Owner
463,806 2016-04-04 0

LOTZE MICHAEL CHIEF SCIENTIFIC OFFICER

  • Officer
0 2016-03-28 0

BENDER JAMES G. VICE PRESIDENT - MANUFACTURING

  • Officer
0 2016-03-11 0

HAWKINS ELMA PRESIDENT & CEO

  • Officer
  • Director
0 2016-03-11 0

FISCHKOFF STEVEN A. CHIEF MEDICAL OFFICER

  • Officer
0 2016-02-04 0

HANDELMAN MICHAEL D CHIEF FINANCIAL OFFICER

  • Officer
0 2016-02-03 0

AYER CAPITAL MANAGEMENT, LP

AYER CAPITAL PARTNERS, LLC

ACM CAPITAL PARTNERS, LLC

  • 10% Owner
No longer subject to file 2015-05-06 0

BRISTOL CAPITAL LLC

  • 10% Owner
444,000 2014-12-31 0

RADVANYI LASZLO CHIEF SCIENTIFIC OFFICER

  • Officer
0 2014-12-05 0

VOYTICKY DAVID J

  • FORMER PRESIDENT
No longer subject to file 2014-08-12 0

AYER CAPITAL MANAGEMENT, LP

AYER CAPITAL PARTNERS, LLC

ACM CAPITAL PARTNERS, LLC

VENKATESAN JAY

  • Director
  • 10% Owner
5,604,015 2013-12-31 0

SINGH MANISH PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
2,546,000 2013-12-30 0

AYER CAPITAL MANAGEMENT, LP

  • Director
  • 10% Owner
560,401,150 2013-05-22 0

SCHROEDER MARTIN

  • Director
1,000,000 2011-08-22 0

ANDREWS WILLIAM H

  • Director
0 2011-03-16 0

COLES L. STEPHEN

  • Director
0 2011-02-22 0

HAMILTON ATLANTIC

  • 10% Owner
0 2010-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FARDIS MARIA - Director - Officer PRESIDENT AND CEO

2020-01-03 A 500,000 a 500,000 0.00 direct

VOGT FREDERICK G - Officer GENERAL COUNSEL

2020-01-03 A 150,000 a 150,000 0.00 direct

GRAF FINCKENSTEIN FRIEDRICH - Officer CHIEF MEDICAL OFFICER

2020-01-03 A 75,000 a 75,000 0.00 direct

FARDIS MARIA - Director - Officer PRESIDENT AND CEO

2020-01-02 F 1,562 $26.68 d 306,691 306,691.00 direct

FARDIS MARIA - Director - Officer PRESIDENT AND CEO

2019-12-02 F 1,894 $22.66 d 308,253 308,253.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments